These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 25549280)

  • 1. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
    Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
    J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Hewings DS; Rooney TP; Jennings LE; Hay DA; Schofield CJ; Brennan PE; Knapp S; Conway SJ
    J Med Chem; 2012 Nov; 55(22):9393-413. PubMed ID: 22924434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.
    Olp MD; Zhu N; Smith BC
    Biochemistry; 2017 Oct; 56(41):5485-5495. PubMed ID: 28945351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polybromo-1-bromodomains bind histone H3 at specific acetyl-lysine positions.
    Chandrasekaran R; Thompson M
    Biochem Biophys Res Commun; 2007 Apr; 355(3):661-6. PubMed ID: 17320048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bromodomain: from epigenome reader to druggable target.
    Sanchez R; Meslamani J; Zhou MM
    Biochim Biophys Acta; 2014 Aug; 1839(8):676-85. PubMed ID: 24686119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands.
    Jennings LE; Measures AR; Wilson BG; Conway SJ
    Future Med Chem; 2014 Feb; 6(2):179-204. PubMed ID: 24467243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
    Hewings DS; Wang M; Philpott M; Fedorov O; Uttarkar S; Filippakopoulos P; Picaud S; Vuppusetty C; Marsden B; Knapp S; Conway SJ; Heightman TD
    J Med Chem; 2011 Oct; 54(19):6761-70. PubMed ID: 21851057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain Histone Readers and Cancer.
    Jain AK; Barton MC
    J Mol Biol; 2017 Jun; 429(13):2003-2010. PubMed ID: 27890782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.
    Hassan AH; Awad S; Al-Natour Z; Othman S; Mustafa F; Rizvi TA
    Biochem J; 2007 Feb; 402(1):125-33. PubMed ID: 17049045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
    Zhao H; Gartenmann L; Dong J; Spiliotopoulos D; Caflisch A
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2493-6. PubMed ID: 24767840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chemical toolbox for the study of bromodomains and epigenetic signaling.
    Wu Q; Heidenreich D; Zhou S; Ackloo S; Krämer A; Nakka K; Lima-Fernandes E; Deblois G; Duan S; Vellanki RN; Li F; Vedadi M; Dilworth J; Lupien M; Brennan PE; Arrowsmith CH; Müller S; Fedorov O; Filippakopoulos P; Knapp S
    Nat Commun; 2019 Apr; 10(1):1915. PubMed ID: 31015424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions.
    Chung CW; Witherington J
    J Biomol Screen; 2011 Dec; 16(10):1170-85. PubMed ID: 21956175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules as tools to study the chemical epigenetics of lysine acetylation.
    Schiedel M; Conway SJ
    Curr Opin Chem Biol; 2018 Aug; 45():166-178. PubMed ID: 29958150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.
    Morinière J; Rousseaux S; Steuerwald U; Soler-López M; Curtet S; Vitte AL; Govin J; Gaucher J; Sadoul K; Hart DJ; Krijgsveld J; Khochbin S; Müller CW; Petosa C
    Nature; 2009 Oct; 461(7264):664-8. PubMed ID: 19794495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exploitation of FRET probes to track bromodomain/histone interactions in cells for bromodomain inhibitors.
    Sasaki K; Yoshida M
    Drug Discov Today Technol; 2016 Mar; 19():51-56. PubMed ID: 27769358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif.
    Marchand JR; Caflisch A
    ChemMedChem; 2015 Aug; 10(8):1327-33. PubMed ID: 26033856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and acetyl-lysine recognition of the bromodomain.
    Mujtaba S; Zeng L; Zhou MM
    Oncogene; 2007 Aug; 26(37):5521-7. PubMed ID: 17694091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.